• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Oncology/Infection

The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials.  For more information on our oncology therapy area please click here or for our infection therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • collapse QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
  • collapse Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
  • collapse Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
  • collapse Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD8931
  • collapse Assessment of the Safety, Tolerability and Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules.
  • collapse Non-interventional observational study to evaluate change of PSA levels in patients with advanced prostate cancer treated with bicalutamide in combination with medical or surgical castration
  • collapse Prevalence of osteoporosis in Korean prostate cancer patients who is reciving LHRH agonist and/or anti-androgen agent
  • collapse A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
  • collapse Protection of Ovarian Function with Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study
  • collapse A Double Blind Randomized Trial of Cediranib versus placebo in patients receiving Paclitaxel/Carboplatin Chemotherapy for the treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013